Development of as table expression system for human drug metabolizing enzymes
Development of as table expression system for human drug metabolizing enzymes
批准号:
07557149
负责人:
YAMAZOE Yasushi
金额:
$7.62万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1997
中文摘要
酿酒酵母和糖酵母菌都含有与哺乳动物细胞相似的基因组和器官系统。后者富含内质网,可应用于哺乳动物细胞表达载体的基因修饰。因此,我们寻找S.pombe表达人P450的可行性。人类肝脏含有至少4种不同的P450 CYP2C亚家族成员(CYP2C8、CYP2C9、CYP2C18和CYP2C19)。这些形式参与各种化学物质的生物转化,包括临床上重要的药物。因此,我们从人肝脏cDNA文库中分离出了CYP2C9、CYP2C18和CYP2C19的cDNA克隆。分离的克隆最初通过ptl2载体导入S.pombe。转化体在内质网中产生了各自的人类CYP2C形式,但由于电子传递成分NADPH-cyt的水平较低,其催化活性仅为微量。P450还原酶。为了克服这种情况,我们引入了NADPH-cyt的cDNA。P450还原酶在S.pombe基因组中获得稳定的活性表达。获得的克隆显示出相当高的P450还原酶活性。使用表达还原酶的细胞,我们再次引入CYP2C形式,结果共表达的细胞显示出高水平的细胞色素P450和P450还原酶的产生。使用奥美拉唑和地西泮等药物的实验清楚地表明这些细胞系对药物代谢研究的有用性。
英文摘要
Both Saccharomyces cerevisiae and Shizosaccharomyces pombe contain genome and organe systems similar to mammalian cells. The latter is rich in endoplasmic reticulum and shown to be applicable for gene modification using expression vector for mammalian cells. Therefore, we looked for the feasibly of S.pombe for expression of human P450. Human livers contain at least 4 different members of CYP2C subfamilies of P450 (CYP2C8, CYP2C9, CYP2C18 and CYP2C19). These forms are involved in the biotrans formation of varies chemicals including clinically important drugs. We, thus, isolated cDNA clones of CYP2C9, CYP2C18, and CYP2C19 from human liver cDNA libraties. The isolated clones were initiallry introduced into S.pombe using pTL2-vectors. The transformants produced respective human CYP2C forms in endoplasmic reticulum but has only trace amounts of their catalytic activities, because of low levels of an electron transport component, NADPH-cyt. P450 reductase. To overcome this situation, we introduced cDNA of NADPH-cyt. P450 reductase in S.pombe genome to obtain stable expression of the activity. The clone obtained showed fairly high level of P450 reducatase activity. Using the reductase expressing cells, we introduced again CYP2C forms and the resultant co-expressed cells showed high levels of production of cytochrome P450 and P450 reductase. Experiments using drugs including omeprazole and dizepam clearly indicate the usefulness of these cell lines for drug metabolism studies.
期刊论文(31)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
K.Fukuda: "Specific CYP3A4 inhibitors in grapefruit juice : furocoumarin dimers as components of drug interaction" Pharmacogenetics. 7. 391-396 (1997)
K.Fukuda:“葡萄柚汁中的特定 CYP3A4 抑制剂:呋喃香豆素二聚体作为药物相互作用的组成部分”药物遗传学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
M.Shimada: "Age-and sex-related alterations of microsomal Drug-and testosterone-oxidizing cytochrome P450 in Sprague-Dawley strain-derived dwarf rats" J.Pharm.Exp.Ther.275. 972-977 (1995)
M.Shimada:“Sprague-Dawley 品系侏儒大鼠中微粒体药物和睾酮氧化细胞色素 P450 的年龄和性别相关变化”J.Pharm.Exp.Ther.275。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
K.P.Vatis: "Nomenclature for N-acetyltransferase" Pharmacogenetics. 5. 1-17 (1995)
K.P.Vatis:“N-乙酰转移酶命名法”药物遗传学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
福田 勝行: "Specific CYP3A4 inhibitors in grapefruit juice:furocoumarin dimers as components of drug interaction" Pharmacogenetics. 7. 391-396 (1997)
Katsuyuki Fukuda:“葡萄柚汁中的特定 CYP3A4 抑制剂:呋喃香豆素二聚体作为药物相互作用的组成部分”药物遗传学 7. 391-396 (1997)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
S. Ozawa: "Primary structures and properties of two related forms of aryl sulotransferases′in human liver" Pharmacogenetics. 5. S135-S140 (1995)
S. Ozawa:“人肝脏中两种相关形式的芳基磺基转移酶的主要结构和特性”药物遗传学 5. S135-S140 (1995)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 30 条
CYP3A4 induction-associated dyslipidemia : a new risk factor for lifestyle disease
-
批准号:22659028
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$1.96万
-
财政年份:2010
-
负责人:YAMAZOE Yasushi
-
依托单位:
Regulation of hepatic lipid metabolism through ileal bile acid-FGF signaling
-
批准号:21390039
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.56万
-
财政年份:2009
-
负责人:YAMAZOE Yasushi
-
依托单位:
Mechanisms for delayed organ toxicity induced by drug and prediction system using comprehensive analysis
-
批准号:19390037
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.56万
-
财政年份:2007
-
负责人:YAMAZOE Yasushi
-
依托单位:
Mechanism for human-specific hepatotoxicity and development of prediction system
-
批准号:17390039
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.66万
-
财政年份:2005
-
负责人:YAMAZOE Yasushi
-
依托单位:
Bile acids, key compounds for the mechanistic analyses of hepatotoxicity, and nuclear receptor interaction
-
批准号:15390043
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.79万
-
财政年份:2003
-
负责人:YAMAZOE Yasushi
-
依托单位:
Human characteristic mechanism of enzyme induction and the prediction
-
批准号:13470510
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.15万
-
财政年份:2001
-
负责人:YAMAZOE Yasushi
-
依托单位:
Grapefruit juice-drug interaction and the prediction
-
批准号:12557225
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.45万
-
财政年份:2000
-
负责人:YAMAZOE Yasushi
-
依托单位:
Role of intestinal oxidative metabolism on first pass effect
-
批准号:09470496
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.93万
-
财政年份:1997
-
负责人:YAMAZOE Yasushi
-
依托单位:
Analysis of mechanism of neonatal imprinting of drug-metabolizing enzymes of rat liver
-
批准号:60480130
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.22万
-
财政年份:1985
-
负责人:YAMAZOE Yasushi
-
依托单位:
海外基金